Jazz Pharmaceuticals Plc (JAZZ)
190.02
+1.05
(+0.56%)
USD |
NASDAQ |
Feb 27, 16:00
190.02
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Research and Development Expense (TTM) : 782.74M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alkermes Plc | 318.36M |
| Amarin Corp. Plc | 17.52M |
| Medtronic Plc | 2.886B |
| Perrigo Co. Plc | 95.40M |
| STERIS Plc (Ireland) | 111.79M |